Clinical trial

Evaluating the Safety and Immunogenicity of MTBVAC

NCT05947890

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-01-30

PhasePHASE2

Study timeline

Study start (actual)2024-01-30Date precision: day

Registry last updated2026-03-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV I Infectionunresolved

Tuberculosisunresolved

Interventions

MTBVACBIOLOGICAL

BCGBIOLOGICAL

Sponsors & collaborators

HIV Vaccine Trials Networklead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Biofabri, S.Lcollaborator

Fred Hutchinson Cancer Centercollaborator

Mapped research locations

Cape TownSouth Africa1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05947890 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.